CQDM

Consortium sur la découverte du médicament Navigation
  • HOME
  • ABOUT
    • MISSION, VISION AND IMPACT
    • STRUCTURE AND GOVERNANCE
    • TEAM
    • MEMBERS
    • COLLABORATORS
    • ANNUAL REPORTS
    • 10th ANNIVERSARY
  • PROGRAMS
    • QUANTUM LEAP
    • SYNERGIQC
    • MENTORSHIP
    • COMPLETED PROGRAMS
  • FUNDED PROJECTS
  • NEWS
  • CONTACT
  • FR
  • SPECIAL INITIATIVES
    • FACS
    • CATALIS
  • HOME
  • ABOUT
    • MISSION, VISION AND IMPACT
    • STRUCTURE AND GOVERNANCE
    • TEAM
    • MEMBERS
    • COLLABORATORS
    • ANNUAL REPORTS
    • 10th ANNIVERSARY
  • PROGRAMS
    • QUANTUM LEAP
    • SYNERGIQC
    • MENTORSHIP
    • COMPLETED PROGRAMS
  • FUNDED PROJECTS
  • NEWS
  • CONTACT
  • FR
  • SPECIAL INITIATIVES
    • FACS
    • CATALIS

Post Archive by Year

Announcement of an investment of close to $8 million dollars in biopharmaceutical research in Québec

Monday June 8th, 2009News & Events

Announcement of a new funding from the Government of Canada

Monday February 23rd, 2009News & Events

LATEST NEWS

  • Amgen becomes a new member of CQDM to further the development of cutting-edge drug discovery
    Monday November 19th, 2018
    Montreal, November 19th 2018 – CQDM is pleased to […]
  • Pfizer Canada renews its support to CQDM with a $550,000 contribution
    Monday November 19th, 2018
    A first project led by Professor Brian Chen at the […]
  • Merck Canada reaffirms its commitment to CQDM with a $3.5M contribution to sustain innovation in Life Sciences
    Monday November 19th, 2018
    Montreal, Quebec – November 19, 2018 – CQDM is […]

About CQDM

  • Our Mission, Vision and Impact
  • Structure & Governance
  • Team
  • Members
  • Collaborators
  • Contact Us

Programs

  • SynergiQC
  • Quantum Leap
  • Mentorship
  • Completed Programs

Follow Us!

Tweets by @CQDM_Canada

© CQDM 2018 // Web: Draxo Marketing

We use cookies and other tracking technologies to improve your browsing experience on our website. By browsing our website, you consent to our use of cookies and other tracking technologies. Accept